- Home
- WHWK vs INFU Comparison
WHWK vs INFU Comparison
Compare WHWK & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHWK | INFU |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 197.0M |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | WHWK | INFU |
|---|---|---|
| Price | $4.73 | $12.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.50 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 431.8K | 168.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.02 | ★ 181.82 |
| EPS | N/A | ★ 0.20 |
| Revenue | $7,145,000.00 | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $60.80 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.60 | $7.29 |
| 52 Week High | $5.50 | $12.97 |
Technical Indicators
Market Signals| Indicator | WHWK | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 62.74 | 64.96 |
| Support Level | $3.79 | $8.60 |
| Resistance Level | $4.84 | $12.97 |
| Average True Range (ATR) | 0.29 | 0.67 |
| MACD | 0.06 | 0.10 |
| Stochastic Oscillator | 86.80 | 82.52 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.